Bluejay Diagnostics/$BJDX
13:30
09:10
04:45
00:25
20:00
1D1W1MYTD1Y5YMAX
About Bluejay Diagnostics
Bluejay Diagnostics Inc is a medical diagnostics company focused on improving patient outcomes using its Symphony System, a cost-effective, rapid, near-patient testing system for sepsis triage and monitoring of disease progression. Bluejay's first product candidate, an IL-6 Test for sepsis, is designed to provide accurate, reliable results in approximately 20 minutes from sample-to-result to help medical professionals make earlier and quicker triage/treatment decisions.
Ticker
$BJDX
Sector
Primary listing
Employees
6
Headquarters
Website
BJDX Metrics
BasicAdvanced
$1.9m
-
-$15.25
0.72
-
Price and volume
Market cap
$1.9m
Beta
0.72
52-week high
$3.85
52-week low
$1.65
Average daily volume
16k
Financial strength
Current ratio
4.882
Quick ratio
4.615
Long term debt to equity
0.414
Total debt to equity
2.168
Interest coverage (TTM)
-8,244.00%
Profitability
EBITDA (TTM)
-6.843
Management effectiveness
Return on assets (TTM)
-62.76%
Return on equity (TTM)
-117.02%
Valuation
Price to book
0.18
Price to tangible book (TTM)
0.18
Price to free cash flow (TTM)
-0.13
Free cash flow yield (TTM)
-770.48%
Free cash flow per share (TTM)
-13.868
Growth
Earnings per share change (TTM)
-96.66%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Bluejay Diagnostics stock?
Bluejay Diagnostics (BJDX) has a market cap of $1.9M as of April 30, 2026.
What is the P/E ratio for Bluejay Diagnostics stock?
The price to earnings (P/E) ratio for Bluejay Diagnostics (BJDX) stock is 0 as of April 30, 2026.
Does Bluejay Diagnostics stock pay dividends?
No, Bluejay Diagnostics (BJDX) stock does not pay dividends to its shareholders as of April 30, 2026.
When is the next Bluejay Diagnostics dividend payment date?
Bluejay Diagnostics (BJDX) stock does not pay dividends to its shareholders.
What is the beta indicator for Bluejay Diagnostics?
Bluejay Diagnostics (BJDX) has a beta rating of 0.72. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.